biomolecules-08-00021.pdf (1002.01 kB)
Circulating microRNA biomarkers in melanoma: tools and challenges in personalised medicine
journal contribution
posted on 2023-06-09, 13:04 authored by Sophie L Mumford, Benjamin TowlerBenjamin Towler, Amy L Pashler, Onur Gilleard, Yella Martin, Sarah NewburySarah NewburyEffective management of melanoma depends heavily on early diagnosis. When detected in early non-metastatic stages, melanoma is almost 100% curable by surgical resection, however when detected in late metastatic stages III and IV, 5-year survival rates drop to ~50% and 10–25%, respectively, due to limited efficacy of current treatment options. This presents a pressing need to identify biomarkers that can detect patients at high risk of recurrence and progression to metastatic disease, which will allow for early intervention and survival benefit. Accumulating evidence over the past few decades has highlighted the potential use of circulating molecular biomarkers for melanoma diagnosis and prognosis, including lactate dehydrogenase (LDH), S100 calcium-binding protein B (S100B) and circulating tumor DNA (ctDNA) fragments. Since 2010, circulating microRNAs (miRNAs) have been increasingly recognised as more robust non-invasive biomarkers for melanoma due to their structural stability under the harsh conditions of the blood and different conditions of sample processing and isolation. Several pre-analytical and analytical variables challenge the accurate quantification of relative miRNA levels between serum samples or plasma samples, leading to conflicting findings between studies on circulating miRNA biomarkers for melanoma. In this review, we provide a critical summary of the circulating miRNA biomarkers for melanoma published to date.
Funding
Identifying miRNA signatures in peripheral blood to detect melanoma recurrence; G2151; MYFANWY TOWNSEND MELANOMA RESEARCH FUND
Understanding the cellular pathways regulated by Dis3L2 in cell proliferation.; G2236; BBSRC-BIOTECHNOLOGY & BIOLOGICAL SCIENCES RESEARCH COUNCIL; BB/P021042/1
Investigating the genetic basis of osteosarcoma in children and domestic dogs.; WB002-60; University of Brighton
History
Publication status
- Published
File Version
- Published version
Journal
BiomoleculesISSN
2218-273XPublisher
MDPIExternal DOI
Issue
2Volume
8Page range
1-25Department affiliated with
- BSMS Publications
Full text available
- Yes
Peer reviewed?
- Yes
Legacy Posted Date
2018-04-30First Open Access (FOA) Date
2018-04-30First Compliant Deposit (FCD) Date
2018-04-30Usage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC